货号:A701042
同义名:
(6R)-BH4 dihydrochloride; (6R)-Tetrahydro-L-biopterin dihydrochloride
Sapropterin 2HCl是一种苯丙氨酸羟化酶(PAH)激活剂,降低血液中的苯丙氨酸浓度,可用于研究苯丙酮尿症。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Hydroxylase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro 61-8048 |
+++
KMO, Ki: 4.8 nM KMO, IC50: 37 nM |
99%+ | |||||||||||||||||
| DMOG | ✔ | 98% | |||||||||||||||||
| Meldonium | ✔ | 95% | |||||||||||||||||
| Nepicastat HCl |
+++
Human dopamine-beta-hydroxylase, IC50: 9 nM Bovine dopamine-beta-hydroxylase, IC50: 8.5 nM |
98% | |||||||||||||||||
| Telotristat etiprate | ✔ | 99%+ | |||||||||||||||||
| Osilodrostat |
++++
11β-hydroxylase, IC50: 2.5 nM |
95% | |||||||||||||||||
| H-DL-Phe(4-Cl)-OH | ✔ | 95% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Sapropterin dihydrochloride is a synthetic version of tetrahydrobiopterin, the naturally occurring pterin cofactor that is required for PAH-mediated phenylalanine hydroxylation[3]. It acts as a pharmacological chaperone, reducing blood Phe concentration and increasing dietary Phe tolerance in BH4-responsive patients with PAH (phenylalanine hydroxylase) deficiency[4]. In patients with PKU (phenylketonuria) who are responders, treatment with BH4 can activate residual PAH (Phenylalanine hydroxylase) enzyme, improve the oxidative metabolism of Phe, and decrease Phe blood levels in some patients. Kuvan (sapropterin dihydrochloride) is available as 100 mg oral tablets and the recommended starting dose is 10 mg/kg/day daily[5]. Sapropterin dihydrochloride (BH4) reduces phenylalanine (Phe) levels and improves white matter integrity in a subset of individuals with phenylketonuria (PKU) known as "responders."[6]. When started after disease onset, oral sapropterin treatment inhibits chronic hypoxia-induced pulmonary hypertension at least in part by recoupling eNOS in the pulmonary vasculature of newborn piglets[7]. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Pregestational diabetes mellitus model | Oral | 10 mg/kg per day | Once daily during gestation | Sapropterin treatment significantly reduced the incidence of congenital heart defects induced by pregestational diabetes mellitus from 59% to 27%, and improved cell proliferation and endothelial nitric oxide synthase (eNOS) function in the fetal heart. | J Am Heart Assoc. 2018 Nov 6;7(21):e009624 |
| Mice | Experimental autoimmune encephalomyelitis (EAE) | Oral | 2 mg/day (~100 mg/kg/day) | Once daily, starting at the day of immunization | To assess the effects of Sapropterin on the course of EAE. Results showed that Sapropterin-treated mice had higher EAE disease scores associated with higher numbers of T-cells infiltrating the spinal cord, but normal T-cell subpopulations in spleen and blood. | Neurotherapeutics. 2021 Jul;18(3):1862-1879 |
| Mice | Hyperphenylalaninemic mouse model | Oral gavage | 20, 40, or 100 mg/kg | Once daily for 4 days | To evaluate the effect of sapropterin treatment upon monoamine neurotransmitter status in hyperphenylalaninemic mice. Results showed that sapropterin treatment significantly increased brain biopterin content but had no effect on serum or brain phenylalanine concentrations. Additionally, sapropterin treatment increased the metabolites HVA and 5-HIAA of dopamine and serotonin, respectively, but did not alter the absolute amounts of dopamine and serotonin. | Mol Genet Metab. 2016 Jan;117(1):5-11 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02677870 | Phenylketonuria | Phase 4 | Recruiting | August 2018 | United States, Ohio ... 展开 >> University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Lori P Schillaci, MD 216-844-3936 lori-anne.schillaci@uhhospitals.org 收起 << |
| NCT00625820 | Kidney Disease ... 展开 >> Albuminuria 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
| NCT00625820 | - | Completed | - | - | |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.18mL 0.64mL 0.32mL |
15.91mL 3.18mL 1.59mL |
31.83mL 6.37mL 3.18mL |
|
| CAS号 | 69056-38-8 |
| 分子式 | C9H17Cl2N5O3 |
| 分子量 | 314.17 |
| SMILES Code | O=C1N=C(N)NC2=C1N[C@@H]([C@@H](O)[C@@H](O)C)CN2.[H]Cl.[H]Cl |
| MDL No. | MFCD00891665 |
| 别名 | (6R)-BH4 dihydrochloride; (6R)-Tetrahydro-L-biopterin dihydrochloride; BH4; (6R)-5,6,7,8-tetrahydro-L-Biopterin (hydrochloride); R-THBP Dihydrochloride; Tetrahydrobiopterin Dihydrochloride; Sapropterin dihydrochloride |
| 运输 | 蓝冰 |
| InChI Key | RKSUYBCOVNCALL-NTVURLEBSA-N |
| Pubchem ID | 135409471 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 190 mg/mL(604.77 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(318.3 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1